Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Free Research Reports on AMGN, C, MON and SFD Issued by the Paragon Report

AMGN, V.ZZE.H
Free Research Reports on AMGN, C, MON and SFD Issued by the Paragon Report

NEW YORK, NY -- (Marketwired) -- 05/30/13 -- The Paragon Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Paragon is an essential resource for hundreds of thousands of investors across the country.

Amgen, Inc. (NASDAQ: AMGN) shares traded in the range of $104.15 to $105.95 Wednesday on volume of over 2.0 million shares traded. The company announced that it has entered into a strategic alliance with Tokyo-based Astellas Pharma Inc. to develop and sell Amgen's medicines in Japan. Shares of Amgen have gained over 21 percent year-to-date.

Find out more about Amgen including full access to the free equity report at: www.ParagonReport.com/AMGN

Citigroup Inc. (NYSE: C) shares have gained approximately 32 percent year-to-date. On Wednesday, the Federal Deposit Insurance Corp. reported U.S. banks posted a profit of $40.3 billion for the first quarter of 2013, the highest quarterly profit ever and a 15.8 percent increase year-over-year.

Find out more about Citigroup including full access to the free equity report at: www.ParagonReport.com/C

Monsanto Company (NYSE: MON) shares traded in the range of $103.34 to $105.86 Wednesday. The company has raised its projections for adjusted fiscal 2013 profit to a range of $4.50 to $4.55 per share, up from previous estimates of $4.40 to $4.50 per share. Shares of Monsanto have gained approximately 11 percent year-to-date.

Find out more about Monsanto including full access to the free equity report at: www.ParagonReport.com/MON

Smithfield Foods, Inc. (NYSE: SFD) shares surged nearly 30 percent on volume of over 67.0 million shares traded Wednesday. Shuanghui International Holdings Ltd. has agreed to purchase the company for approximately $4.72 billion, or $34 a share, which is a 31 percent premium to Tuesday's closing price.

Find out more about Smithfield Foods including full access to the free equity report at: www.ParagonReport.com/SFD

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today